Please assess the completion status of the following clinical trial:

Trial Title: Implementing Cabenuva in Arkansas HIV Programs

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Persons, 18-years old and older~* Receiving Cabenuva injections (following registered USPI) at one of the six clinics in this study~* Ability to provide informed consent~* Patients who would receive Cabenuva at home: Living within 40-miles from the three clinics randomized to the at-home arm of the study~Exclusion Criteria:~* Pregnant or breastfeeding women, or women who plan to become pregnant during the study period.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Clinic visit arm (Type: NO_INTERVENTION): Patient will receive Cabenuva injection at the clinic
- Home visit arm (Type: EXPERIMENTAL): Patient will receive Cabenuva injection at home

Based on this trial design, predict the completion outcome and termination type (if applicable).